Latest Manufacturing News

Amaero Ltd has secured a A$4.6 million order from Titomic under their exclusive five-year agreement, marking a significant step in supplying critical refractory and titanium powders for defense applications.

Southern Cross Electrical Engineering Limited has landed $90 million in new contracts spanning battery storage, education facilities, and water infrastructure, reinforcing its foothold in key growth sectors.

PeopleIN Limited has announced the sale of its Health and Community brands to Healthcare Australia for $20.25 million, unlocking capital to fuel growth in infrastructure, defence, and agriculture sectors.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

Micro-X Limited has secured $6 million through a share placement to accelerate commercialisation of its innovative medical imaging technologies, with strategic partner Billion Prima increasing its stake to 8.5%. The capital raise supports key clinical trials and product development milestones.

Micro-X has raised $6.18 million through a placement that sees strategic partner Billion Prima increase its stake to 8.6%, funding key commercial and manufacturing scale-up initiatives in medical imaging.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

GemLife has secured a $21 million greenfield site in Townsville, Queensland, aiming to develop over 500 new homes and boost its Land Lease Community portfolio.

First Graphene has successfully produced 600 tonnes of graphene enhanced cement, marking a key milestone in sustainable construction with significant CO2 reductions and multiple UK trial projects underway.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Elsight Limited has landed a substantial US$21.2 million contract for early 2026 deliveries, marking a dramatic increase in forward orders and reinforcing its role in the global defence and uncrewed systems sector.

Prospech Limited advances its Korsnäs rare earth project by transitioning from flotation upgrades to a targeted hydrometallurgical program with ANSTO Minerals, aiming to unlock value from a significant historical concentrate stockpile in Finland.